{"title":"CORRIGENDUM: α-Triazolylboronic Acids: A Novel Scaffold to Target FLT3 in AML","authors":"","doi":"10.1002/cmdc.202400982","DOIUrl":null,"url":null,"abstract":"<p>Correction to “α-Triazolylboronic Acids: A Novel Scaffold to Target FLT3 in AML”</p><p>Maria Luisa Introvigne, Lorenza Destro, Luca Mologni, Valentina Crippa, Paolo Zardi, Francesco Fini, Fabio Prati, Emilia Caselli, Alfonso Zambon, “α-Triazolylboronic Acids: A Novel Scaffold to Target FLT3 in AML”, <i>ChemMedChem</i> <b>2024</b>, <i>19</i>, e202400622 DOI: https://doi.org/10.1002/cmdc.202400622</p><p>The full first names of the authors of this paper were omitted upon initial publication, and Fabio Prati was incorrectly entered as “L. F. Prati”. All author names are correct and complete as shown.</p>","PeriodicalId":147,"journal":{"name":"ChemMedChem","volume":"20 6","pages":""},"PeriodicalIF":3.4000,"publicationDate":"2025-01-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cmdc.202400982","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ChemMedChem","FirstCategoryId":"3","ListUrlMain":"https://chemistry-europe.onlinelibrary.wiley.com/doi/10.1002/cmdc.202400982","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0
Abstract
Correction to “α-Triazolylboronic Acids: A Novel Scaffold to Target FLT3 in AML”
Maria Luisa Introvigne, Lorenza Destro, Luca Mologni, Valentina Crippa, Paolo Zardi, Francesco Fini, Fabio Prati, Emilia Caselli, Alfonso Zambon, “α-Triazolylboronic Acids: A Novel Scaffold to Target FLT3 in AML”, ChemMedChem2024, 19, e202400622 DOI: https://doi.org/10.1002/cmdc.202400622
The full first names of the authors of this paper were omitted upon initial publication, and Fabio Prati was incorrectly entered as “L. F. Prati”. All author names are correct and complete as shown.
期刊介绍：
Quality research. Outstanding publications. With an impact factor of 3.124 (2019), ChemMedChem is a top journal for research at the interface of chemistry, biology and medicine. It is published on behalf of Chemistry Europe, an association of 16 European chemical societies.
ChemMedChem publishes primary as well as critical secondary and tertiary information from authors across and for the world. Its mission is to integrate the wide and flourishing field of medicinal and pharmaceutical sciences, ranging from drug design and discovery to drug development and delivery, from molecular modeling to combinatorial chemistry, from target validation to lead generation and ADMET studies. ChemMedChem typically covers topics on small molecules, therapeutic macromolecules, peptides, peptidomimetics, and aptamers, protein-drug conjugates, nucleic acid therapies, and beginning 2017, nanomedicine, particularly 1) targeted nanodelivery, 2) theranostic nanoparticles, and 3) nanodrugs.
Contents
ChemMedChem publishes an attractive mixture of:
Full Papers and Communications
Reviews and Minireviews
Patent Reviews
Highlights and Concepts
Book and Multimedia Reviews.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
